Search results
Results from the WOW.Com Content Network
Help; Learn to edit; Community portal; Recent changes; Upload file; Special pages
The COVID-19 pandemic in Japan has resulted in 33,803,572 [1] confirmed cases of COVID-19 and 74,694 [1] deaths, along with 33,728,878 recoveries.. The Japanese government confirmed the country's first case of the disease on 16 January 2020 in a resident of Kanagawa Prefecture who had returned from Wuhan, China. [3]
It was established on 14 February to advise the Cabinet of Japan from a medical point of view, following the first confirmed COVID-19 death in Japan. [1] [2]Takaji Wakita, Director of the National Institute of Infectious Diseases, chairs the Expert Meeting and Shigeru Omi who was instrumental in SARS measures as director of WHO Regional Office for the Western Pacific and later worked to ...
Yoshihide Suga, the prime minister of Japan vaccinated with a COVID-19 vaccine. COVID-19 vaccination in Japan started later than in most other major economies. [4] The country has frequently been regarded as "slow" in its vaccination efforts.
The Government divided all the districts into three zones based on the spread of the virus—green, red, and orange—with relaxations applied accordingly. [184] On 17 May, the lockdown was further extended until 31 May by the National Disaster Management Authority .
COVID-19 Response Acceleration Task Force (Indonesian: Gugus Tugas Percepatan Penanganan COVID-19) was a task force that coordinates and oversees the Indonesian government's efforts to accelerate the mitigation of the COVID-19 pandemic.
[243] [244] Since then, the virus has spread to the country's 81 provinces. [245] National and local governments have been imposing community quarantines since March 15, 2020, as a measure to limit the spread of the virus. [246] These include the Luzon-wide enhanced community quarantine (ECQ) that was implemented in March–May 2020.
Virus infections start when viral particles bind to host surface cellular receptors. [158] Protein modeling experiments on the spike protein of the virus soon suggested that SARS‑CoV‑2 has sufficient affinity to the receptor angiotensin converting enzyme 2 (ACE2) on human cells to use them as a mechanism of cell entry . [ 159 ]